×
About 35,198 results

ALLMedicine™ Arrhythmias Center

Research & Reviews  10,701 results

Safety and Effect on Length of Stay of Intravenous Sotalol Initiation for Arrhythmia Ma...
https://doi.org/10.1111/jce.15852
Journal of Cardiovascular Electrophysiology; Rizkallah DH, Refaat MM

Feb 5th, 2023 - Sotalol is a class III antiarrhythmic drug with beta-adrenergic blocking activity, used to manage both supraventricular and ventricular arrhythmias. This article is protected by copyright. All rights reserved.

Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the ...
https://doi.org/10.1097/CRD.0000000000000426
Cardiology in Review; Akboga MK, Inanc IH et. al.

Feb 4th, 2023 - Atrial fibrillation (AF) is one of the most encountered arrhythmias in clinical practice. It is also estimated that the absolute AF burden may increase by greater than 60% by 2050. It is inevitable that AF will become one of the largest epidemics ...

Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart ...
https://doi.org/10.1016/j.intimp.2023.109795
International Immunopharmacology; Fu H, Kong B et. al.

Feb 4th, 2023 - Intestinal microbial metabolites are a risk factor for cardiovascular diseases, and phenylacetylglutamine (PAGln) is a newly discovered intestinal metabolite in the latest study. In addition, elevated plasma PAGln concentration was associated with...

Acute Cerebrovascular Events Secondary to Patients Undergoing Catheter Ablation to Arrhythmias
https://clinicaltrials.gov/ct2/show/NCT05694273

Feb 3rd, 2023 - With the steady development of catheter ablation, it has gradually become the main treatment of various arrhythmias. Antithrombotic and anticoagulant therapy after catheter ablation determines the occurrence of perioperative bleeding and ischemic ...

Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiot...
https://doi.org/10.1001/jamaoncol.2022.6869
JAMA Oncology; Buck B, Chum AP et. al.

Feb 3rd, 2023 - Ibrutinib has been associated with serious cardiotoxic arrhythmias. In preclinical models, these events are paralleled or proceeded by diffuse myocardial injury (inflammation and fibrosis). Yet whether this is seen in patients or has implications ...

see more →

Guidelines  19 results

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic ...
https://doi.org/10.1016/j.echo.2022.03.012
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...

2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in ...
https://doi.org/10.1016/j.hrthm.2022.04.022
Heart Rhythm; Groh WJ, Bhakta D et. al.

May 3rd, 2022 - This international multidisciplinary document is intended to guide electrophysiologists, cardiologists, other clinicians, and health care professionals in caring for patients with arrhythmic complications of neuromuscular disorders (NMDs). The doc...

Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVI...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598679
JACC. Cardiovascular Imaging; Phelan D, Kim JH et. al.

Dec 12th, 2020 - As our understanding of the complications of coronavirus disease-2019 (COVID-19) evolve, subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular dysfunction in the absence of significant clinical symptoms represents ...

ACR Appropriateness Criteria® Blunt Chest Trauma-Suspected Cardiac Injury.
https://doi.org/10.1016/j.jacr.2020.09.012
Journal of the American College of Radiology : JACR; , Stojanovska J et. al.

Nov 7th, 2020 - Blunt cardiac injuries range from myocardial concussion (commotio cordis) leading to fatal ventricular arrhythmias to myocardial contusion, cardiac chamber rupture, septal rupture, pericardial rupture, and valvular injuries. Blunt injuries account...

Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart R...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291987
JACC. Clinical Electrophysiology; Lakkireddy DR, Chung MK et. al.

Aug 21st, 2020 - Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted health care delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variabil...

see more →

Drugs  696 results see all →

Clinicaltrials.gov  1,216 results

Acute Cerebrovascular Events Secondary to Patients Undergoing Catheter Ablation to Arrhythmias
https://clinicaltrials.gov/ct2/show/NCT05694273

Feb 3rd, 2023 - With the steady development of catheter ablation, it has gradually become the main treatment of various arrhythmias. Antithrombotic and anticoagulant therapy after catheter ablation determines the occurrence of perioperative bleeding and ischemic ...

Effect of Ketamine Versus Sevoflurane On The Right Ventricular Pressure
https://clinicaltrials.gov/ct2/show/NCT05582213

Feb 2nd, 2023 - Critical pulmonary stenosis (PS) is a life-threatening congenital heart disease which manifest during the neonatal period with cyanosis. Surgical valvotomy was the procedure of choice for critical PS; however, balloon pulmonary valvoplasty (BPV) h...

Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.
https://clinicaltrials.gov/ct2/show/NCT05508087

Feb 2nd, 2023 - Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected bio...

Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
https://clinicaltrials.gov/ct2/show/NCT04144725

Feb 1st, 2023 - This is an observational study of patients with suspected coronary artery disease referred to coronary computed tomography angiography (CCTA). The plan is to include 1000 patients prior to CCTA at two centers. Blood samples for biomarker measureme...

Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
https://clinicaltrials.gov/ct2/show/NCT01791543

Feb 1st, 2023 - The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard r...

see more →

News  1,349 results

Yelp Reviews in Cardiology; Viagra's Unfulfilled Promise; Catheter RDN at 10 Years
https://www.medpagetoday.com/cardiology/prevention/102896

Jan 31st, 2023 - Want good Yelp reviews? Positive online reviews of cardiologists tended to focus on patient‐perceived cardiologist competency, thoroughness, and positive staff interactions. (Journal of the American Heart Association) Former Pfizer executive remar...

FDA Greenlights BTK Inhibitor Zanubrutinib for CLL/SLL
https://www.medpagetoday.com/hematologyoncology/leukemia/102724

Jan 20th, 2023 - The FDA has approved the Bruton's tyrosine kinase (BTK) inhibitor zanubrutinib (Brukinsa) for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Approval was based on results from the phase III S...

Screen All Surgery Patients for Cannabis Use, New Guidelines Say
https://www.medpagetoday.com/surgery/anesthesiology/102488

Jan 3rd, 2023 - Surgical candidates undergoing anesthesia should be screened universally for cannabis use, new guidelines from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) stated. Anesthesiologists should ask all patients abo...

ADHD Meds and Cardiovascular Safety: New Data
https://www.medscape.com/viewarticle/984666

Nov 28th, 2022 - A new study provides some reassurance regarding the cardiovascular safety of medications used to treat attention-deficit/hyperactivity disorder (ADHD). A large meta-analysis showed no statistically significant association between use of stimulant ...

Meta-Analysis Finds ADHD Drugs Not Linked to Risk of Cardiovascular Disease
https://www.medpagetoday.com/psychiatry/adhd-add/101914

Nov 23rd, 2022 - Use of medications for attention deficit-hyperactivity disorder (ADHD) was not associated with increased cardiovascular disease (CVD) risk, a systematic review and meta-analysis of 19 studies showed, although the researchers cautioned that a modes...

see more →

Patient Education  98 results see all →